c-ANCA (c-ANCA)

A positive cytoplasmic pattern, especially once PR3-ANCA is confirmed, is associated with a small family of small-vessel vasculitis conditions. MedlinePlus links it to granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA). GPA is the classic match: most people with active GPA test positive for both c-ANCA and PR3-ANCA, according to MedlinePlus, and the disease tends to inflame blood vessels in the lungs, kidneys, nose, sinuses, and ears. If you searched your sinus and breathing trouble alongside a positive ANCA and landed on Wegener's, GPA is simply the modern name for it.

This is also where the two-step logic became official. The revised 2017 international consensus concluded that high-quality PR3-ANCA and MPO-ANCA immunoassays can serve as the primary screen for suspected GPA and MPA, a shift from the 1999 approach that required the immunofluorescence pattern first and the antigen test only as confirmation. Either way, the antigen-specific result, rather than the glow alone, is the part that carries diagnostic weight.

That matters most when the two disagree. A c-ANCA pattern that reads positive while the PR3 immunoassay comes back negative, or a weak positive that no antigen test confirms, is a likeness without a matching fingerprint. It pulls suspicion toward vasculitis far less than a confirmed PR3-ANCA does, which is exactly why your doctor weighs the antigen result so heavily.

The pattern's biggest limitation is that other conditions can light up the same stain, producing what is effectively a false positive for vasculitis. A PMC review on ANCA detection notes that a positive ANCA can appear in inflammatory bowel disease, autoimmune liver disease, connective tissue diseases, infections, and drug-induced vasculitis. The same review stresses that a PR3- or MPO-ANCA reaches high sensitivity and specificity for vasculitis only in the right clinical context, under what it calls a gating policy that depends on the clinical information the lab is given.

A negative result is genuinely reassuring, with limits. MedlinePlus describes it as no ANCA found, which makes autoimmune vasculitis an unlikely cause of your symptoms. It does not erase the possibility entirely. ANCA can be negative in some people who do have disease, and a clinician with strong suspicion may keep looking with other blood tests and imaging. Negative means the sketch never appeared, not that every suspect has an alibi.

Once vasculitis is diagnosed and treated, the question shifts from what it is to whether it is coming back, and the titer gets watched. A rise or reappearance of ANCA during remission is associated with a higher risk of relapse, and research on relapse risk reports that PR3-ANCA-positive patients tend to relapse more often than MPO-ANCA-positive ones. The honest caveat from that same research is that ANCA monitoring is only modestly predictive, and there is no definitive relapse biomarker. A rising titer is a reason to look closely with your doctor, not a verdict on its own. Our guide to reading flagged values covers why a single moved number is a prompt rather than a panic.

c-ANCA rarely stands alone on a report. On an autoimmune panel it sits alongside antibodies such as rheumatoid factor and complement proteins like C3 and C4, each adding context the cytoplasmic glow can't supply by itself. If your panel came back with several autoimmune markers flagged at once, the guide to reading an autoimmune panel walks through how clinicians weigh them together. The throughline for c-ANCA holds from the first glow to the confirmed diagnosis: the pattern opens the case, while the PR3 fingerprint and often a biopsy close it.